Prodrugs of HIV protease inhibitors

Details for Australian Patent Application No. 2005270124 (hide)

Owner Abbott Laboratories

Inventors Flosi, William J.; Klein, Larry L.; Wang, Xiu C.; Grampovnik, David J.; Degoey, David A.; Kempf, Dale J.

Agent Spruson & Ferguson

Pub. Number AU-B-2005270124

PCT Pub. Number WO2006/014282

Priority 60/585,710 06.07.04 US

Filing date 29 June 2005

Wipo publication date 9 February 2006

Acceptance publication date 8 September 2011

International Classifications

C07F 9/00 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 35/00 (2006.01) Antineoplastic agents

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014282 Priority application(s): WO2006/014282

8 September 2011 Application Accepted

  Published as AU-B-2005270124

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270129-Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions

2005270105-Methods and apparatus for mixing compressed digital bit streams